Tetragastrin is a synthetic tetrapeptide corresponding to the C-terminal active site of gastrin. Sequence features include an amidated phenylalanine critical for receptor interaction. Compact structure supports precise conformation in solution. Researchers employ it as a minimal model for gastrin signaling and receptor-binding studies.
CAT No: T32-1
CAS No:1947-37-1
Synonyms/Alias:tetragastrin;Gastrin tetrapeptide;1947-37-1;Cholecystokinin tetrapeptide;Tetragastrin [JAN];CCK-4;Gastrin tetrapeptide amide;cholecystokinin-4;Tetragastrin (JAN);CCRIS 3246;4-7-cholecystokinin-7 (swine);0OL293AV80;Trp-Met-Asp-Phe-NH(2);WMDF-NH(2);TETRAGASTRIN [WHO-DD];UNII-0OL293AV80;CHEMBL120632;(3S)-3-[[(2S)-2-[[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid;CHEBI:137728;L-Trp-L-Met-L-Asp-L-Phe-NH(2);L-Phenylalaninamide, L-tryptophyl-L-methionyl-L-alpha-aspartyl-;L-tryptophyl-L-methionyl-L-aspartylphenyl-Alaninamide;L-tryptophyl-L-methionyl-L-aspartyl-L-phenylalaninamide;L-Triptophyl-L-methyionyl-L-alpha-aspartyl-L-phenylalaninamide;L-tryptophyl-L-methionyl-L-alpha-aspartyl-L-phenylalaninamide;AOC Tetragastrin;AOC Tetrapeptide;AOC-Tetrapeptide;L-PHENYLALANINAMIDE, L-TRYPTOPHYL-L-METHIONYL-L-.ALPHA.-ASPARTYL-;Cholecystokinin 4;L-Phenylalaninamide, N-((phenylmethoxy)carbonyl)-L-tryptophyl-L-methionyl-L-aspartyl-;N-((Phenylmethoxy)carbonyl)-L-tryptophyl-L-methionyl-L-aspartyl-L-phenylalaninamide;(3S)-3-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}propanoic acid;(S)-4-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)amino)-3-((S)-2-((S)-2-amino-3-(1H-indol-3-yl)propanamido)-4-(methylthio)butanamido)-4-oxobutanoic acid;Tetrapeptide, Gastrin;Tetragastrin (hydrochloride);Cholecystokinin-Tetrapeptide;Cholecystokinin (30-33);CKK-4;(3S)-3-(((2S)-2-(((2S)-2-amino-3-(1H-indol-3-yl)propanoyl)amino)-4-methylsulfanylbutanoyl)amino)-4-(((2S)-1-amino-1-oxo-3-phenylpropan-2-yl)amino)-4-oxobutanoic acid;(3S)-3-((2S)-2-((2S)-2-amino-3-(1H-indol-3-yl)propanamido)-4-(methylsulfanyl)butanamido)-3-(((1S)-1-carbamoyl-2-phenylethyl)carbamoyl)propanoic acid;4, Cholecystokinin;CCK (30-33);Gastrin(14-17)(human);L-Tryptophyl-L-methionyl-L-.alpha.-aspartyl-L-phenylalaninamide;SCHEMBL9710792;CHEBI:32210;DTXSID601027522;BDBM50024317;AKOS040744602;FG108885;H-Trp-Met-Asp-Phe-NH2; H-WMDF-NH2;MS-30582;HY-125556;CS-0092217;D01456;SR-01000883973;SR-01000883973-1;BRD-K70369756-001-01-3;(S)-4-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-3-((S)-2-((S)-2-amino-3-(1H-indol-3-yl)propanamido)-4-(methylthio)butanamido)-4-oxobutanoic acid;3-{2-[2-Amino-3-(1H-indol-3-yl)-propionylamino]-4-methylsulfanyl-butyrylamino}-N-(1-carbamoyl-2-phenyl-ethyl)-succinamic acid;
1. Myotropic activity of allatostatins in tenebrionid beetles
2. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More